Optic

Optic is an AI-driven biopharma company empowering biotech investors and drug developers with advanced asset discovery and strategic intelligence tools. Their BIOPTIC platform - featuring autonomous AI agents - can identify high value assets and partnership opportunities, while their B1 and B2 models can accelerate early stage drug discovery. With a team of experts and a growing number of partners, Optic is enabling smarter, faster decisions across venture creation, licensing and R&D.